Gravity Analytica

Stereotaxis to Report Third Quarter 2024 Financial Results on November 11, 2024

STXS 10.23.2024

SERA-AI Powered Highlights

Date of Upcoming Event:2024-11-11

Name of Upcoming Event:Stereotaxis third quarter 2024 financial results conference call

Full Press Release SEC Filings Our STXS Tweets

About Gravity Analytica

Recent Filings

01.02.2025 - 4 Statement of changes in beneficial ownership of securities

PDF Version

ST. LOUIS,Oct. 23, 2024(GLOBE NEWSWIRE) --Stereotaxis(NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2024 third quarter onMonday, November 11, 2024at the close of theU.S.financial markets. The Company will host a conference call and webcast at4:30 p.m. ETthat day to discuss the Company’s results and corporate developments.

What:		Stereotaxisthird quarter 2024 financial results conference call

When:		Monday, November 11, 2024, at4:30 p.m. ET(1:30 p.m. PT)

Dial In Number:		To access the live call, dial 800-715-9871 (US andCanada) or 1-646-307-1963 (International) and give the participant pass code 7792742.

Webcast:		To access the live and replay webcast, please visit the investor relations section of Stereotaxis’ website athttp://ir.stereotaxis.com/.

Call Replay:		A phone replay of the call will be available for one month beginning approximately four hours following the end of the call. To request access for a replay of the conference call, pleaseclick here.

AboutStereotaxisStereotaxis(NYSE: STXS) is a pioneer and global leader in innovative surgical robotics for minimally invasive endovascular intervention. Its mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide unsurpassed patient care with robotic precision and safety, expand access to minimally invasive therapy, and enhance the productivity, connectivity, and intelligence in the operating room.Stereotaxistechnology has been used to treat over 150,000 patients acrossthe United States,Europe,Asia, and elsewhere. For more information, please visitwww.stereotaxis.com.

Investor Contacts:David L. FischelChairman and Chief Executive Officer

Kimberly PeeryChief Financial Officer

314-678-6100Investors@Stereotaxis.com

Source: Stereotaxis, Inc.

Please be aware that the following content has been generated by an AI system and may contain errors, inconsistencies, or outdated information. It is provided as-is without any warranties or guarantees of accuracy. We strongly recommend using this content as a starting point for further research and consultation with relevant experts or authorities. We disclaim any liability for damages or losses resulting from the use or reliance on this content.Please note that this is a beta version of the Gravity Analytica LLC’s AI Service which isstill undergoing final testing before its official release. Theplatform, its software and all content found on it are provided on an“as is” and “as available” basis. Gravity Analytica LLC does not give any warranties,whether express or implied, as to the suitability or usability of thisservice, webpage, or its software or any of its content.Should you encounter any bugs, glitches, lack of functionality orother problems on the website, please let us know immediately so wecan rectify these accordingly. Your help in this regard is greatlyappreciated! You can write to us at this addressteam@gravityanalytica.com